An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204)

Go Back to All Clinical Trials

An Umbrella Study of INCMGA00012 Alone and in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-Based Chemotherapy (POD1UM-204)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

Conditions:
Endometrial Cancer
Age: Between 18 Year(s) - 100 Year(s)
Gender: Female

Other Inclusion Criteria:

1) Histologically confirmed diagnosis of advanced or metastatic endometrial cancer with disease progression on or after treatment with at least 1 platinum-containing regimen for advanced or metastatic disease. 2) Willing to provide tumor tissue sample (fresh or archived).

You may not be eligible for this study if the following are true:

1) Histologically confirmed diagnosis of sarcoma of the uterus. 2) Has disease eligible for potentially curative treatment with standard chemotherapy, surgical resection, or chemoradiotherapy. 3) Receipt of anticancer therapy within 28 days of the first administration of study treatment, with the exception of localized radiotherapy.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Perlmutter Cancer Center

Clinical Trials & Research Studies